The patent application WO2018171400, concerning acarbose, has entered the U.S. national phase. This indicates that patent protection is being sought or has been granted for acarbose within the United States based on this international filing [1].
What is acarbose used for?
Acarbose is a medication used to manage type 2 diabetes. It works by slowing down the digestion of carbohydrates in the digestive tract, which helps to reduce the rise in blood sugar levels after meals [2].
How does acarbose work?
Acarbose is an alpha-glucosidase inhibitor. It targets and inhibits enzymes in the small intestine that are responsible for breaking down complex carbohydrates into simple sugars. By delaying this process, acarbose leads to a more gradual absorption of glucose into the bloodstream, preventing post-meal hyperglycemia [2].
When does the patent for acarbose expire?
Patent expiry dates for drugs are complex and can vary. For acarbose, the original patents have long since expired, allowing for generic versions to be available. However, new patent applications like WO2018171400 may relate to specific formulations, manufacturing processes, or new uses of acarbose, which could have their own patent protection periods [1]. Information on specific patent expiry dates can be found on resources such as DrugPatentWatch.com [1].
What are the potential new uses or formulations being patented for acarbose?
The specifics of what WO2018171400 covers would need to be examined in the full patent document. However, patent applications in this area often relate to:
* Improved formulations for better bioavailability or patient compliance.
* Novel methods of manufacturing acarbose that are more efficient or cost-effective.
* New therapeutic applications or combinations with other drugs for treating diabetes or related conditions [1].
Who else is developing acarbose treatments?
Many pharmaceutical companies manufacture and market generic acarbose products. The patent landscape can reveal which companies are actively seeking new intellectual property related to acarbose, potentially indicating future product development or market strategies [1].
What are the side effects of acarbose?
Common side effects of acarbose include gastrointestinal issues such as diarrhea, flatulence, and abdominal discomfort. These are often related to the undigested carbohydrates reaching the large intestine and being fermented by bacteria [3].
How does acarbose compare to other diabetes medications?
Acarbose is typically used in conjunction with diet and exercise, and sometimes with other diabetes medications like metformin or sulfonylureas. Unlike some other diabetes drugs, acarbose does not cause hypoglycemia when used as monotherapy [2]. It targets postprandial glucose levels specifically. Other classes of diabetes drugs include DPP-4 inhibitors, SGLT2 inhibitors, and GLP-1 receptor agonists, which have different mechanisms of action and side effect profiles.
What are the clinical trial results for acarbose?
Clinical trials have demonstrated acarbose's efficacy in lowering postprandial blood glucose levels and glycosylated hemoglobin (HbA1c) in patients with type 2 diabetes. Studies also show a reduction in the risk of developing type 2 diabetes in individuals with impaired glucose tolerance [2].
---
Sources:
[1] https://drugpatentwatch.com/
[2] Acarbose - Drug Information
[3] Acarbose Side Effects